| Ytd | 22.54% | |
| 1y | 53.83% |
| Open | 384.09 | Prev Close | 387.10 | Low | 383.05 | High | 392.00 | Mkt Cap | 19.12B |
| Vol | 608.59K | Avg Vol | 729.91K | EPS | 10.48 | P/E | 36.81 | Forward P/E | 24.29 |
| Beta | 1.29 | Short Ratio | 2.34 | Inst. Own | 95.51% | Dividend | 0.80 | Div Yield | 0.21 |
| Ex Div Date | 08-25 | Earning | 10-22 | 50-d Avg | 464.90 | 200-d Avg | 442.81 | 1yr Est | 575.50 |
The Stock Whisper Index is a market indicator highlighting stocks that are attracting heightened int
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recogni
TD Cowen analyst Gautam Khanna maintains Carpenter Technology (NYSE:CRS) with a Buy and lowers th
Carpenter Technology Corporation (NYSE: CRS) announced that its Board of Directors has declared a qu
Carpenter (CRS) might move higher on growing optimism about its earnings prospects, which is reflect
Keybanc analyst Michael Leshock maintains Carpenter Technology (NYSE:CRS) with a Overweight and l
Carpenter Technology (NYSE:CRS) has outperformed the market over the past 15 years by 1.67% on an an
Carpenter Technology's Specialty Alloys Operations post record margins as productivity and product m
Carpenter Technology NYSE: CRS said fiscal 2026 marked another record year for earnings, while the c
Tompkins Financial Corp lowered its holdings in Carpenter Technology Corporation (NYSE: CRS) by 98.3
Poolbeg Pharma PLC (AIM:POLB), the clinical-stage biopharmaceutical company, has secured a South Kor
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improveme
[url="]Genmab A/S[/url](Nasdaq: GMAB) and AbbVie (NYSE: ABBV) announced today positive topline resul
Carpenter Technology (NYSE:CRS) has outperformed the market over the past 20 years by 1.26% on an an
Wells Fargo analyst David Strauss maintains Carpenter Technology (NYSE:CRS) with a Equal-Weight a
Defense stocks are on track for a seventh straight weekly loss, a first for XAR since 2011, as Iran
Dan Loeb’s Third Point cut its Carpenter Technology stake by 31% in the second quarter, ahead of lea